Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Nutrition Reviews
|
November 1, 1996
Functional foods in North America
W H Glinsmann
The American Journal of Clinical Nutrition
|
October 1, 1992
Why is the Food and Drug Administration interested in dietary fatty acids and thrombosis?
W H Glinsmann
Lancet (London, England)
|
April 18, 1970
Cyclic A.M.P. in depression and mania
G R Berg, W H Glinsmann
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1975
Inactivation of rabbit muscle phosphorylase phosphatase by cyclic AMP-dependent kinas
F L Huang, W H Glinsmann
The Biochemical Journal
|
April 1, 1978
Maximizing the purification of the activated glucocorticoid receptor by DNA-cellulose chromatography
H J Eisen, W H Glinsmann
The American Journal of Clinical Nutrition
|
November 1, 1993
The public health significance of dietary fructose
W H Glinsmann, B A Bowman
Biochemical and Biophysical Research Communications
|
February 5, 1973
Activation of glycogen synthetase and inactivation of phosphorylase kinase by the same phosphoprotein phosphatase
F J Zieve, W H Glinsmann
The American Journal of Clinical Nutrition
|
July 1, 1995
Perspective on the 1986 Food and Drug Administration assessment of the safety of carbohydrate sweeteners: uniform definitions and recommendations for future assessments
W H Glinsmann, Y K Park
European Journal of Biochemistry
|
November 15, 1976
Separation and characterization of two phosphorylase phosphatase inhibitors from rabbit skeletal muscle
F L Huang, W H Glinsmann
Annual Review of Nutrition
|
January 1, 1992
Fat substitutes: a regulatory perspective
J E Vanderveen, W H Glinsmann
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Nutrition Reviews
|
November 1, 1996
Functional foods in North America
W H Glinsmann
The American Journal of Clinical Nutrition
|
October 1, 1992
Why is the Food and Drug Administration interested in dietary fatty acids and thrombosis?
W H Glinsmann
Lancet (London, England)
|
April 18, 1970
Cyclic A.M.P. in depression and mania
G R Berg, W H Glinsmann
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1975
Inactivation of rabbit muscle phosphorylase phosphatase by cyclic AMP-dependent kinas
F L Huang, W H Glinsmann
The Biochemical Journal
|
April 1, 1978
Maximizing the purification of the activated glucocorticoid receptor by DNA-cellulose chromatography
H J Eisen, W H Glinsmann
The American Journal of Clinical Nutrition
|
November 1, 1993
The public health significance of dietary fructose
W H Glinsmann, B A Bowman
Biochemical and Biophysical Research Communications
|
February 5, 1973
Activation of glycogen synthetase and inactivation of phosphorylase kinase by the same phosphoprotein phosphatase
F J Zieve, W H Glinsmann
The American Journal of Clinical Nutrition
|
July 1, 1995
Perspective on the 1986 Food and Drug Administration assessment of the safety of carbohydrate sweeteners: uniform definitions and recommendations for future assessments
W H Glinsmann, Y K Park
European Journal of Biochemistry
|
November 15, 1976
Separation and characterization of two phosphorylase phosphatase inhibitors from rabbit skeletal muscle
F L Huang, W H Glinsmann
Annual Review of Nutrition
|
January 1, 1992
Fat substitutes: a regulatory perspective
J E Vanderveen, W H Glinsmann
Page
of 3